AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimlix-M 1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Aelix Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimlix-M 1 Tablet SR

Diabeticard-Duo 1mg Extended-Release tablet is an anti-diabetic medication combining two active ingredients for adult type 2 diabetes management. It regulates blood glucose levels. Diabeticard-Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to monitor blood cell counts and liver function.

Uses of Glimlix-M 1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimlix-M 1 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take one Glimlix-M 1 SR tablet with a meal.

Common Side effects of Glimlix-M 1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimlix-M 1 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimlix-M 1 Tablet SR should be administered with a meal.

How Glimlix-M 1 Tablet SR works:

Glimlix-M SR, a single-tablet formulation, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimlix-M 1 Tablet SR with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimlix-M 1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Concurrent breastfeeding and use of Glimlix-M 1 Tablet SR is contraindicated due to potential infant toxicity indicated by available data.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimlix-M 1 Tablet SR cautiously, potentially requiring a modified dosage. Physician consultation is recommended. Glimlix-M 1 Tablet SR is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glimlix-M 1 Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. A reduced initial dose is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Glimlix-M 1 Tablet SR :

Should you forget a Glimlix-M 1 Tablet SR dose, take it immediately. However, if your next dose is nearly due, omit the missed dose and resume your usual medication timetable. Never take a double dose.

Facts to Know About Glimlix-M 1 Tablet SR

LabelValue
Addictive None.
Type of Medication Medication for diabetes

FAQs on Glimlix-M 1 Tablet SR

Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Indeed, Glimlix-M 1 Tablet SR carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This complication, also termed Metformin-associated lactic acidosis (MALA), is an infrequent adverse reaction to metformin. Consequently, it poses a significant risk to individuals with pre-existing kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, queasiness, vomiting, abdominal discomfort, or a slowed pulse. Should you experience any of these signs, discontinue Glimlix-M 1 Tablet SR and seek immediate medical attention.
Glimlix-M 1 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication helps regulate blood sugar when used with a healthy diet and exercise regimen. Glimepiride's action involves stimulating the pancreas to release more insulin. Metformin reduces hepatic glucose production and enhances insulin responsiveness. This dual-drug therapy is unsuitable for type 1 DM.
Glimlix-M 1 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimlix-M 1 Tablet SR use can indeed lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as peripheral neuropathy (manifesting as tingling, numbness in extremities, and weakness), urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental Vitamin B12 intake, at least annually, has been proposed by some investigators.
Glimlix-M 1 Tablet SR can indeed lower blood sugar, potentially causing hypoglycemia. This low blood sugar can manifest as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and feelings of anxiety or shakiness. The risk increases with missed meals, alcohol consumption, excessive physical activity, or concurrent use of other diabetes medications. Therefore, consistent blood sugar monitoring is crucial. Always carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimlix-M 1 Tablet SR and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Glimlix-M 1 Tablet SR
40
MRP 49
18% off